BOULDER, Colo.--(BUSINESS WIRE)--Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, announced today the validation and launch of a new method of ...
Thoracic surgeon Gaetano Rocco, MD, holding a component of the "E-Nose," a noninvasive lung cancer test that produced promising results in a clinical trial at Memorial Sloan Kettering. Detecting lung ...
Researchers have shown that a test called ORACLE can predict lung cancer survival at the point of diagnosis better than currently used clinical risk factors. This could help doctors make more informed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback